TrialStat EDC

Fast, Compliant, Fully Unified – EDC + IWRS + ePRO + Coding

TrialStat Portal

Real-Time Data & Analytics | Make Study Decision Sooner

Don't Settle For Standard EDC Technology & Services

With TrialStat EDC you'll have your studies up and running quicker, capture your study data more efficiently with fewer errors and reduce your overall study costs.

We're Supporting COVID-19 Research

In times of crisis we all need to step up and help. Effective immediately, we are offering TrialStat’s eClinical Platform and Data Analytics Portal at discounted rates to researchers working on solutions related to COVID-19. With a focus on ease of use, speed of implementation, and real-time data analytics, TrialStat’s data capture suite enables fast study start up and ensures all stakeholders have relevant, customized, timely insight into all aspects of study data and areas of risk or potential delays. We welcome the opportunity to collaborate with our industry colleagues on the path to treatments or cures – please contact [email protected] to learn more about this program.

Have questions about enrolling in a clinical trial, or about the COVID-19 Vaccines?

If you're a member of the general public and have questions about the approved vaccines, or are interested in enrolling in a clinical trial please have a look at the following resources:

From the entire TrialStat team, we wish you and yours good health as our industry and our communities work together to navigate this outbreak over the coming weeks and months. Thank you for #StayingHome and #FlatteningTheCurve!

 

Our Latest COVID-19 Research News

Request Your Demo Today!

From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?

Immunome Discovers Antibodies Capable of Neutralizing Multiple SARS-CoV-2 Variants, Including the South African Variant, in Pseudovirus Testing

Excerpt from the Press Release: EXTON, Pa.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human ...
Read More

MRI Shows Heart Damage in Nearly Half of Patients with Severe COVID-19

Excerpt from the Article: MRI scans reveal myocarditis, scarring, infarction, and ischemia in recovered patients with elevated troponin ...
Read More

Genetics May Play Role in Determining Immunity to COVID-19

Excerpt from the Press Release: Neutralizing antibodies develop within two weeks of a SARS-CoV-2 infection, but their durability ...
Read More

Imaging Shows COVID-19 Creates a Body Self-Attack

Excerpt from the Article: CT, MRI, and ultrasound images reveal the myriad of ways the virus prompts the ...
Read More

Atea Pharmaceuticals Announces Publication of Preclinical Data Highlighting Potent Activity of AT-527 Against SARS-CoV-2

Excerpt from the Press Release: BOSTON, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), ...
Read More

A Deep Dive On mRNA Vaccines

Excerpt from the Article: February 11, 2021 | Messenger RNA (mRNA) vaccines were the focus of a symposium ...
Read More

Verily links with Janssen for at-home COVID-19 immune system study

Excerpt from the Article: Verily is teaming up with Johnson & Johnson’s Janssen division to observe the body’s ...
Read More

How to Handle a COVID-19 Vaccine-Related Adenopathy Seen on Breast MRI

Excerpt from the Article: The Hospital of the University of Pennsylvania offers guidance – BI-RADS scoring and follow-up ...
Read More

In a Time of COVID, Dealmakers Take a Shine to Diagnostics and Vaccines

Excerpt from the Article: If you had an inkling that more money went to vaccine and diagnostic companies ...
Read More